ES2074396A1 - Sistema de administracion nasal de cianocobalamina (vitamina b12). - Google Patents

Sistema de administracion nasal de cianocobalamina (vitamina b12).

Info

Publication number
ES2074396A1
ES2074396A1 ES09300604A ES9300604A ES2074396A1 ES 2074396 A1 ES2074396 A1 ES 2074396A1 ES 09300604 A ES09300604 A ES 09300604A ES 9300604 A ES9300604 A ES 9300604A ES 2074396 A1 ES2074396 A1 ES 2074396A1
Authority
ES
Spain
Prior art keywords
cyanocobalamine
vitamin
nasal administration
hlb
polyglycolized glyceride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300604A
Other languages
English (en)
Other versions
ES2074396B1 (es
Inventor
Huertas Jose Luis Berenguer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Priority to ES9300604A priority Critical patent/ES2074396B1/es
Publication of ES2074396A1 publication Critical patent/ES2074396A1/es
Application granted granted Critical
Publication of ES2074396B1 publication Critical patent/ES2074396B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SISTEMA DE ADMINISTRACION NASAL DE CIANOCOBALAMINA (VITAMINA B12). EL SISTEMA CONSISTE EN LA UTILIZACION DE UNA FORMULACION QUE PUEDE SER ISOTONICA O NO, DE VISCOSIDAD APROPIADA, QUE CONTIENE BIOADHESIVOS Y SE PRESENTA EN LA FORMA DE GELES, LOCIONES, POMADAS, CREMAS, SUSPENSIONES O POLVOS, INCLUYENDO ADEMAS CONSERVADORES, PROMOTORES DE LA ABSORCION, ESTABILIZANTES FISICOS Y QUIMICOS, AMORTIGUADORES DE PH, SOLVENTES Y VEHICULOS APROPIADOS O COMPATIBLES CON LA CIANOCOBALAMINA. EN UNA COMPOSICION TIPICA DE ACUERDO CON LA INVENCION Y POR CADA 100 ML., PARTICIPAN CIANOCOBALAMINA, 0,41G; SORBITOL AL 70 POR CIENTO; 5 ML.; PANTOTENOL, 2 ML.; METILPAROBEN, 0,20 G; ACIDO ACETICO, 0,18 G; ACETATO SODICO, 0,15 G; METILCELULOSA, 2 G; GLICERINA, 1,50 ML.; CLORURO SODICO, AGUA, 1000 ML.; GLICERIDO POLIGLICOLIZADO, (HLB=14), 20 ML.; GLICERIDO POLIGLICOLIZADO (HLB=3,5), 5 ML.; ISOESTEORATO DE POLIGLICERILO, 10 ML., PROPILPREREBEN, 0,02 G. EN LA FIGURA SE OBSERVA EL ACUSADO CONTRASTE EN LA VELOCIDAD DE ABSORCION POR VIA ORAL Y POR VIA INTRANASAL DE LA INVENCION.
ES9300604A 1993-03-24 1993-03-24 Sistema de administracion nasal de cianocobalamina (vitamina b12). Expired - Fee Related ES2074396B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9300604A ES2074396B1 (es) 1993-03-24 1993-03-24 Sistema de administracion nasal de cianocobalamina (vitamina b12).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9300604A ES2074396B1 (es) 1993-03-24 1993-03-24 Sistema de administracion nasal de cianocobalamina (vitamina b12).

Publications (2)

Publication Number Publication Date
ES2074396A1 true ES2074396A1 (es) 1995-09-01
ES2074396B1 ES2074396B1 (es) 1996-04-01

Family

ID=8281228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9300604A Expired - Fee Related ES2074396B1 (es) 1993-03-24 1993-03-24 Sistema de administracion nasal de cianocobalamina (vitamina b12).

Country Status (1)

Country Link
ES (1) ES2074396B1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094842A1 (en) * 2004-03-30 2005-10-13 Transition Therapeutics Inc. Vitamin b12-containing compositions and methods of use
WO2012056299A1 (en) * 2010-10-29 2012-05-03 Troikaa Pharmaceuticals Limited Nasal compositions of vitamin b12

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005987A1 (en) * 1985-04-16 1986-10-23 Nastech Pharmaceutical Company, Inc. Aerosol compositions for nasal delivery of vitamin b12
ES8800047A1 (es) * 1986-04-08 1987-11-01 Nastech Pharm Co Un procedimiento para preparar una composicion terapeutica a base de vitamina b12
EP0416773A2 (en) * 1989-08-31 1991-03-13 Takeda Chemical Industries, Ltd. Vitamin B12 composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005987A1 (en) * 1985-04-16 1986-10-23 Nastech Pharmaceutical Company, Inc. Aerosol compositions for nasal delivery of vitamin b12
ES8800047A1 (es) * 1986-04-08 1987-11-01 Nastech Pharm Co Un procedimiento para preparar una composicion terapeutica a base de vitamina b12
EP0416773A2 (en) * 1989-08-31 1991-03-13 Takeda Chemical Industries, Ltd. Vitamin B12 composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094842A1 (en) * 2004-03-30 2005-10-13 Transition Therapeutics Inc. Vitamin b12-containing compositions and methods of use
WO2012056299A1 (en) * 2010-10-29 2012-05-03 Troikaa Pharmaceuticals Limited Nasal compositions of vitamin b12
EA024475B1 (ru) * 2010-10-29 2016-09-30 Троикаа Фармасьютикалз Лимитед Композиции витамина в12 для интраназального применения

Also Published As

Publication number Publication date
ES2074396B1 (es) 1996-04-01

Similar Documents

Publication Publication Date Title
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
HK1029933A1 (en) Activated vitamin d3 emulsion-type lotions.
CY1108117T1 (el) Φαρμακολογικως δραστικες ενωσεις με δυο ομοιοπολικως συνδεδεμενα δραστικα στοιχεια (αναστολεας διαυλων νατριου/αγωνιστης υποδοχεα ρ2υ2)για την αγωγη των βλεννογονιων επιφανειων
IE870993L (en) Nasal administration compositions.
MX9605665A (es) Bis (resorcinil) triazinas.
AU8052282A (en) Compensation in gyroscopic flowmeter
NZ336787A (en) Sizing of paper using a sizing agent in a dispersant system comprising a cationic organic compound and an anionic polyelectrolyte
OA09739A (en) Moisturizing vehicle for topical application of vitamin a acid.
ZA98303B (en) Aqueous suspension for nasal administration
DE3581768D1 (de) Tensidepraeparate.
ES2074396A1 (es) Sistema de administracion nasal de cianocobalamina (vitamina b12).
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
MX9804451A (es) Composiciones de proteccion solar, estabilizadas.
FI974372A0 (fi) Tärkkelysjohdannaisen sisältävä "one-shot"-hartsiemulsio paperin liimausta varten
IT1182101B (it) Perfezionamento nei sistemi di cuscinetti per punte di trivelle da roccia
AU3949485A (en) Roll stability with air suspension
WO1997046247B1 (en) Anti-tussive composition comprising essence of anise, senega dry extract and licorice root extract
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
AU6352300A (en) Computer-based system for simplification of tax collections and remittances for internet and mail order commerce
IE811626L (en) Anthracycline glycosides
IT240707Y1 (it) Struttura per l'introduzione di mezzi in pressione in assi, alberio simili
FR2710268B1 (fr) Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
IT8441576A1 (it) Dispositivo per controllare l'angolo relativo fra le due parti componenti un veicolo articolato
NZ224812A (en) Derivatives of 2',3'-dideoxycytidine and pharmaceutical compositions
ITMI920699A0 (it) Composizione acquosa gelificabile per il recupero assistito del petrolio

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040503